Physician profile
Ryan Potter
NPI 1730107095
$3,139.04
in general payments reported to CMS, 2019-2025
19 companies · $58.65 in 2025
The $58.65 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $1,787 · 2021: $310 · 2022: $102 · 2023: $41.82 · 2024: $26.46 · 2025: $58.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $1,461.97 | 2020 | |
| Medtronic USA, INC. | $395.33 | 2019-2020 | |
| Medtronic, INC. | $338.74 | 2021-2022 | |
| Boston Scientific Corporation | $183.28 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Centinel Spine, LLC | $103.79 | 2019 | |
| Radius Health, INC. | $91.70 | 2019-2020 | |
| Lilly USA, LLC | $78.00 | 2019-2022 | |
| Vertiflex, INC. | $71.23 | 2019 | |
| Zyla Life Sciences, INC. | $66.38 | 2019-2020 | |
| Spr Therapeutics, INC | $58.65 | 2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $56.31 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $41.82 | 2023 | Belbuca, Xtampza |
| Si-Bone, INC. | $39.38 | 2019 | |
| Daiichi Sankyo INC. | $34.71 | 2019 | |
| Pfizer INC. | $31.65 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $29.70 | 2019 | |
| Supernus Pharmaceuticals, INC. | $22.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.98 | 2019 | |
| Flowonix Medical Incorporated | $15.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.